Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1698146 | 1.00 | CYP2D6 (0.49) | CYP2D6CYP2C19 | |
| SCHEMBL1698141 | 1.00 | CYP2D6 (0.49) | CYP2D6CYP2C19 | |
| SCHEMBL1141590 | 0.87 | CYP2D6 (0.41) | CYP2D6CYP2C19 | |
| SCHEMBL1141647 | 0.84 | CYP2D6 (0.40) | CYP2D6CYP2C19 | |
| SCHEMBL11393510 | 0.83 | CYP2D6 (0.37) | CYP2D6CYP2C19 | |
| SCHEMBL3181541 | 0.82 | CYP2D6 (0.38) | CYP2D6CYP2C19 | |
| SCHEMBL9664338 | 0.81 | CYP2D6 (0.36) | CYP2D6CYP2C19 | |
| SCHEMBL13320133 | 0.80 | CYP2D6 (0.36) | CYP2D6CYP2C19 | |
| SCHEMBL9360172 | 0.78 | CYP2D6 (0.33) | CYP2D6CYP2C19 | |
| SCHEMBL2761436 | 0.72 | CYP2D6 (0.40) | CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2585569-A1 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2013-05-01 | — | — | EP | claimed |
| WO-2011163337-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2011-12-29 | — | — | WO | claimed |
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | claimed |
| EP-3085759-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-07 | — | — | EP | disclosed |
| EP-3085759-A2 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2016-10-26 | — | — | EP | disclosed |
| EP-2585569-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-08-24 | — | — | EP | disclosed |
| US-8609603-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2013-12-17 | — | — | US | disclosed |
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110308555-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | CYP2D6 792/4885CYP2C19 354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.